A dive into the complexity of type i interferon antiviral functions

Journal of Hepatology

Volumn 56, Issue 3, 2012, Pages 726-728

  Touzot, Maxime ^a,b   Soumelis, Vassili ^a,b   Asselah, Tarik ^c,d,e  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSTITUT CURIE   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON STIMULATED GENE FACTOR 3; RETINOIC ACID INDUCIBLE PROTEIN I;

ANTIVIRAL ACTIVITY; CHIKUNGUNYA ALPHAVIRUS; GENE EXPRESSION; GENE OVEREXPRESSION; GENE PRODUCT; GENE TARGETING; GENETIC SCREENING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVIEW; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS INHIBITION; VIRUS REPLICATION; WEST NILE FLAVIVIRUS; YELLOW FEVER FLAVIVIRUS;

EID: 84857371876     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.07.009     Document Type: Note

References (13)

1. A. Isaacs, and J. Lindenmann Virus interference I. The interferon Proc R Soc Lond B Biol Sci 147 1957 258 267
2. E.C. Borden, G.C. Sen, G. Uze, R.H. Silverman, R.M. Ransohoff, and G.R. Foster Interferons at age 50: past, current and future impact on biomedicine Nat Rev Drug Discov 6 2007 975 990
3. T. Asselah, and P. Marcellin New direct-acting antivirals' combination for the treatment of chronic hepatitis C Liver Int 31 2011 68 77
4. G. Trinchieri Type I interferon: friend or foe? J Exp Med 207 2010 2053 2063
5. A.N. Theofilopoulos, R. Baccala, B. Beutler, and D.H. Kono Type I interferons (alpha/beta) in immunity and autoimmunity Annu Rev Immunol 23 2005 307 336
6. M.J. de Veer, M. Holko, M. Frevel, E. Walker, S. Der, and J.M. Paranjape Functional classification of interferon-stimulated genes identified using microarrays J Leukoc Biol 69 2001 912 920
7. J.W. Schoggins, S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, and P. Bieniasz A diverse range of gene products are effectors of the type I interferon antiviral response Nature 472 2011 481 485
8. K.J. Helbig, D.T. Lau, L. Semendric, and H.A. Harley Beard MR Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector Hepatology 42 2005 702 710
9. L.I. Brodsky, L.I.J. Wahed AS, J.E. Tavis, T. Tsukahara, and M.Y. Taylor A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients PLoS One 2 2007 584
10. T. Asselah, I. Biche, S. Narguet, A. Sabbagh, I. Laurendeau, and M.P. Ripault Gene expression and hepatitis C virus infection Gut 58 2008 846 858
11. M. Sarasin-Filipowicz, E.J. Oakeley, F.H. Duong, V. Christen, L. Terracciano, and Filipowicz Interferon signaling and treatment outcome in chronic hepatitis C Proc Natl Acad Sci USA 105 2008 7034 7039
12. T. Asselah, I. Bieche, and S. Narguet Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C Gut 57 2008 516 524
13. E. Foy, K. Li, C. Wang, R. Sumpter Jr., M. Ikeda, and S.M. Lemon Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease Science 16 2003 1145 1148